Frequency of Dyslipidemia in Diabetic Anemic Patients with and without Nephropathy
DOI:
https://doi.org/10.51273/esc22.251835Keywords:
Diabetes, Anemia, Nephropathy, DyslipidemiaAbstract
Objective: To compare frequency of dyslipidemia in anemic diabetics with and without nephropathy.
Method: The study design was comparative cross-sectional Hemotology Department. Eighty (n=80) patients who visited Diabetes management centre were included in the study. Sampling was done by using Non-probability, consecutive sampling technique. The participants were categorized in 2 groups. Group I consists of 40 anemic patients with diabetes and without nephropathy, group II includes 40 anemic diabetic nephropathy patients. Demo-graphic details were noted. Informed consent was obtained before taking blood sample. Analysis of samples for cholesterol level was done using ELISA technique. Reports were assessed and levels were noted. All the data was noted in specified proforma and analyzed through SPSS 22.0.
Results: During this study a total of 80 patients were inducted having mean ages of 49.2±7 years. There were 41.3% males and 58.3% female patients. Total iron binding capacity was 345±61.6mcg/dl, serum iron level was 24.24±5.54mmol/l. Mean serum cholesterol level in patients without diabetic nephropathy was 196.55 + 53.56mg/dl and in patients with diabetic nephropathy 221.11 + 41.11, p-value 0.04. Mean serum triglyceride levels were 170.35 + 35.94 in patients with diabetic nephropathy and 199.35 + 55.94, p-value 0.002. There were 37.5% patients having dyslipidemia without hephropathy and 70% in patients with hephropathy. p- value 0.001.
Conclusion: Study concluded that patients having any degree of diabetes associated nephropathy with concomitant anemia have increased frequency of dyslipidemia as compared to diabetics without nephropathy but having anemia.
How to cite: Fareed M, Razaq O, Rehman L, Dar R, Zahid S, Raza A. Frequency of Dyslipidemia in Diabetic Anemic Patients
with and without Nephropathy. Esculapio - JSIMS 2022;18(03):267-271